In the News

386 News Items found
(From left) David Scheinberg, Andrew Zelenetz, and Joseph Jurcic are using monoclonal antibodies to improve the treatment of patients with leukemia and lymphoma.
Therapies designed to target cancer while sparing healthy tissue show benefit, but have not yet reached full potential.
MSK physician-scientist Charles Sawyers and SKI computational biologist Dana Pe’er
Researchers learn how prostate cancer cells change their type to survive treatment.
Virtual community events in April
Free, virtual programs in English and Spanish for our community.
a sneaky man on a sneaky mission
In the Lab
Cancer cells have a sneaky ability to hide out in the body for years at a time. MSK scientists are looking for ways to flush them out.
Pictured: Joan Massagué
In the Lab
A team of investigators from Memorial Sloan Kettering has shown for the first time that tumor growth, metastasis, and chemotherapy resistance are connected to the same molecular changes inside breast cancer cells.
a cartoon of a cancer cell spooning glutamine from a jar
Feature
While sugar gets most of the attention as a cancer fuel, other nutrients can be equally important.
A man in his 70s (prostate cancer patient) smiling for camera
A new technology shows great promise for imaging and treating advanced forms of prostate cancer.
Pouring white wine into a glass
Feature
Hear from our experts about a new study linking alcohol consumption and melanoma risk.
Left-handed and right-handed KRas molecules
In the Lab
MSK chemists are focusing on developing small-molecule drugs to target KRas, an important cancer protein.
Pictured: Filippo Giancotti
In the Lab
A new Memorial Sloan Kettering study has identified one of the proteins fueling the spread of some breast cancers, and researchers hope their findings will lead to the development of new diagnostic tools and drugs.